There is an ongoing battle to suppress Hydroxychloroquine (HCQ), a cheap and effective drug for the treatment of Covid-19. The campaign against HCQ is carried out through slanderous political statements, media smears, not to mention an authoritative peer reviewed "evaluation" published on May 22nd by The Lancet, which was based on fake figures and test trials.
The study was allegedly based on data analysis of 96,032 patients hospitalized with COVID-19 between Dec 20, 2019, and April 14, 2020 from 671 hospitals Worldwide. The database had been fabricated. The objective was to kill the Hydroxychloroquine (HCQ) cure on behalf of Big Pharma.
While The Lancet article was retracted, the media casually blamed "a tiny US based company" named Surgisphere whose employees included "a sci-fi writer and adult content model" for spreading "flawed data" (Guardian). This Chicago based outfit was accused of having misled both the WHO and national governments, inciting them to ban HCQ. None of those trial tests actually took place.
While the blame was placed on Surgisphere, the unspoken truth (which neither the scientific community nor the media have acknowledged) is that the study was coordinated by Harvard professor Mandeep Mehra under the auspices of Brigham and Women's Hospital (BWH) which is a partner of the Harvard Medical School.
When the scam was revealed, Dr. Mandeep Mehra who holds the Harvey Distinguished Chair of Medicine at Brigham and Women's Hospital apologized:
I have always performed my research in accordance with the highest ethical and professional guidelines. However, we can never forget the responsibility we have as researchers to scrupulously ensure that we rely on data sources that adhere to our high standards.
It is now clear to me that in my hope to contribute this research during a time of great need, I did not do enough to ensure that the data source was appropriate for this use. For that, and for all the disruptions – both directly and indirectly – I am truly sorry. (emphasis added)
Mandeep R. Mehra, MD, MSC (official statement on BWH website)
But that "truly sorry" note was just the tip of the iceberg. Why?
Studies on Gilead Science's Remdesivir and Hydroxychloroquine (HCQ) Were Conducted Simultaneously by Brigham and Women's Hospital (BWH)
An independent data and safety monitoring board (DSMB) overseeing the trial met on April 27 to review data and shared their interim analysis with the study team. Based upon their review of the data, they noted that remdesivir was better than placebo from the perspective of the primary endpoint, time to recovery, a metric often used in influenza trials. Recovery in this study was defined as being well enough for hospital discharge or returning to normal activity level.
Preliminary results indicate that patients who received remdesivir had a 31% faster time to recovery than those who received placebo (p < 0.001). Specifically, the median time to recovery was 11 days for patients treated with remdesivir compared with 15 days for those who received placebo. Results also suggested a survival benefit, with a mortality rate of 8.0% for the group receiving remdesivir versus 11.6% for the placebo group (p = 0.059).(emphasis added)
In the NIH's earlier February 21, 2020 report (released at the outset of the study), the methodology was described as follows:
… A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed with coronavirus disease 2019 (COVID-19) …
Numbers. Where? When?
The February 21 report confirmed that the first trial participant was "an American who was repatriated after being quarantined on the Diamond Princess cruise ship" that docked in Yokohama (Japanese Territorial Waters). "Thirteen people repatriated by the U.S. State Department from the Diamond Princess cruise ship" were selected as patients for the placebo trial test. Ironically, at the outset of the study, 58.7% of the "confirmed cases" Worldwide (542 cases out of 924) (outside China), were on the Diamond Cruise Princess from which the initial trial placebo patients were selected.
Where and When: The trial test in the 68 selected sites? That came at a later date because on February 19th (WHO data), the US had recorded only 15 positive cases (see Table Below).
... "A total of 68 sites ultimately joined the study—47 in the United States and 21 in countries in Europe and Asia." (emphasis added)
In the final May 22 NEJM report entitled Remdesivir for the Treatment of Covid-19 — Preliminary Report:
... There were 60 trial sites and 13 subsites in the United States (45 sites), Denmark (8), the United Kingdom (5), Greece (4), Germany (3), Korea (2), Mexico (2), Spain (2), Japan (1), and Singapore (1). Eligible patients were randomly assigned in a 1:1 ratio to receive either remdesivir or placebo. Randomization was stratified by study site and disease severity at enrollment
The Washington Post applauded Anthony Fauci's announcement (April 29):
... "The preliminary results, disclosed at the White House by Anthony S. Fauci, … fall short of the magic bullet or cure… But with no approved treatments for Covid-19,[Lie] Fauci said, it will become the standard of care for hospitalized patients …The data shows that remdisivir has a clear-cut, significant, positive effect in diminishing the time to recovery," Fauci said. 2/2
lag - "Why doctors won't speak up" "Medical cancel culture- NYT, Rolling Stones, all did hit jobs" Death threats, medical investigations ". These physicians knew it but still thought it was more important to let patients know. There are thousands afraid of losing license. "Prescribe it for themselves & family but not for their own patients out of fear of this"......pretty much says it all.
UBETYURASKI - Around the 2:00:45 mark, where the good Dr says "we couldn't get our message out. The media..." I hope someone starts Congressional hearings as to why the media blocked this information.
NW Sean - (9:43) Best clear statement on masks... (10:54) PCR test confirms "a month out coughing up dead virus = vaccine" (12:44) Faucci was Dir of the NIH and knows about the effectiveness of treating this virus. (15:33) Pediatrician talks about its effect on children. (22:00) Virtual education is a failure: (27:00-39:01) LAUSD is outed on their demands to re-open schools. https://www.utla.net/sites/default/files/reopeningschoolslayoutdraft_0.pdf
Chloroquine, a relatively safe, effective and cheap drug used for treating many human diseases including malaria, amoebiosis and human immunodeficiency virus is effective in inhibiting the infection and spread of SARS CoV in cell culture. The fact that the drug has significant inhibitory antiviral effect when the susceptible cells were treated either prior to or after infection suggests a possible prophylactic and therapeutic use.
"You mentioned side effects. The side effects for the xxx vaccine sound concerning. We looked after the second dose at least 80% of participants experienced a systemic side effect, ranging from severe chills, to fevers. So - are these vaccines safe?"
Bill Gates: "Well the FDA, not being pressured, will look hard at that. The FDA is the gold standard of regulators and their current guidance on this is if they stick with that is very very appropriate.
The side effects were not super severe, that is it didn't cause permanent health problems for the things.
……
it's great that we have multiple of them that are going out there."
"Bill, but the data shows that everyone with a high dose had a side effect"
Bill Gates: "Yeah, but some of that is not dramatic, where it's just you know super painful.
We need to make sure there are lots of severe side effects (???)
The FDA will do a good job at that, despite the pressure."
…
"You said more than 7 billion doses is what we need."
Bill Gates: "Well, if what you are trying to do is block all the transmission, then you need to get 70 to 80% coverage on a global basis, so unbelievably big numbers."
"I mean you are talking about a global vaccination program, without a vaccine that has been fully developed yet and a massive scaling up of how to produce one of several vaccines."
…
"Today we learned Pfizer is going to get nearly 2 billion, Moderna receiving 438 million in tax payer money, and yet both companies have said they will not sell the vaccine at cost, they will make a profit on it.
Should pharmaceutical companies profit off this vaccine research that tax payer have helped fund."
…
"…that the vaccine will be free for Americans, or affordable,so that means the government will help purchase it from companies that are making a profit off of that we helped fund the research for.Do you see any problem with that?"
This is dummy text. It is not meant to be read. Accordingly, it is difficult to figure out when to end it. But then, this is dummy text. It is not meant to be read. Period.
ConversionConversion EmoticonEmoticon